{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T08:52:39Z","timestamp":1794214359693,"version":"4.8.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.urolonc.2015.11.011","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T15:03:42Z","timestamp":1450364622000},"page":"237.e1-237.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["The decrease of cyclin B2 expression inhibits invasion and metastasis of bladder cancer"],"prefix":"10.1016","volume":"34","author":[{"given":"Cheng-yong","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-tong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-yi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-long","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2015.11.011_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/03008880802285032","article-title":"The global burden of urinary bladder cancer","volume":"218","author":"Parkin","year":"2008","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"10.1016\/j.urolonc.2015.11.011_bib2","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2015.11.011_bib3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35077213","article-title":"Proliferation, cell cycle and apoptosis in cancer","volume":"411","author":"Evan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2015.11.011_bib4","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1038\/sj.onc.1202494","article-title":"The cyclin B2 promoter depends on NF-Y, a trimer whose CCAAT-binding activity is cell-cycle regulated","volume":"18","author":"Bolognese","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2015.11.011_bib5","first-page":"4000","article-title":"Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication","volume":"60","author":"Soria","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2015.11.011_bib6","first-page":"3107","article-title":"Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma","volume":"54","author":"Nishida","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2015.11.011_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF01226270","article-title":"Different expression patterns of cyclins A, D1 and E in human colorectal cancer","volume":"122","author":"Wang","year":"1996","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.urolonc.2015.11.011_bib8","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1073\/pnas.90.3.1112","article-title":"Redundant cyclin overexpression and gene amplification in breast cancer cells","volume":"90","author":"Keyomarsi","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2015.11.011_bib9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1349-7006.1995.tb02442.x","article-title":"Frequent amplification of the cyclin E gene in human gastric carcinomas","volume":"86","author":"Akama","year":"1995","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.urolonc.2015.11.011_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-13-1","article-title":"Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome","volume":"13","author":"Shubbar","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2015.11.011_bib11","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1158\/1078-0432.CCR-06-1461","article-title":"NF-Y-dependent cyclin B2 expression in colorectal adenocarcinoma","volume":"13","author":"Park","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2015.11.011_bib12","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1164\/rccm.200401-127OC","article-title":"Discrimination of human lung neoplasm from normal lung by two target genes","volume":"170","author":"Hofmann","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.urolonc.2015.11.011_bib13","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1158\/0008-5472.CAN-08-4133","article-title":"HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas","volume":"69","author":"De Martino","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2015.11.011_bib14","first-page":"555","article-title":"The role and mechanism of high expression of cyclin B2 in MEN1 insulinoma","volume":"63","author":"Wu","year":"2011","journal-title":"Sheng Li Xue Bao"},{"key":"10.1016\/j.urolonc.2015.11.011_bib15","first-page":"137","article-title":"Grade-dependent effects on cell cycle progression and apoptosis in response to doxorubicin in human bladder cancer cell lines","volume":"34","author":"Stravopodis","year":"2009","journal-title":"Int J Oncol"},{"key":"10.1016\/j.urolonc.2015.11.011_bib16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5301\/JBM.2010.6088","article-title":"Use of serum circulating CCNB2 in cancer surveillance","volume":"25","author":"Mo","year":"2010","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.urolonc.2015.11.011_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1242\/dev.118.1.229","article-title":"Isolation of the murine cyclin B2 cDNA and characterization of the lineage and temporal specificity of expression of the B1 and B2 cyclins during oogenesis, spermatogenesis and early embryogenesis","volume":"118","author":"Chapman","year":"1993","journal-title":"Development"},{"key":"10.1016\/j.urolonc.2015.11.011_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0092-8674(90)90599-A","article-title":"Cyclin is a component of maturation-promoting factor from Xenopus","volume":"60","author":"Gautier","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2015.11.011_bib19","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1093\/nar\/28.22.4410","article-title":"The tumour suppressor protein p53 can repress transcription of cyclin B","volume":"28","author":"Krause","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.urolonc.2015.11.011_bib20","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1073\/pnas.95.8.4344","article-title":"Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero","volume":"95","author":"Brandeis","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2015.11.011_bib21","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/j.1460-2075.1995.tb07153.x","article-title":"Human cyclins B1 and B2 are localized to strikingly different structures: B1 to microtubules, B2 primarily to the Golgi apparatus","volume":"14","author":"Jackman","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.urolonc.2015.11.011_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.devcel.2013.02.008","article-title":"Hec1-dependent cyclin B2 stabilization regulates the G2-M transition and early prometaphase in mouse oocytes","volume":"25","author":"Gui","year":"2013","journal-title":"Dev Cell"},{"key":"10.1016\/j.urolonc.2015.11.011_bib23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/BF01269891","article-title":"Overexpression of cyclin B1 in human colorectal cancers","volume":"123","author":"Wang","year":"1997","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.urolonc.2015.11.011_bib24","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/mrd.1023","article-title":"Requirement of cyclin B2, but not cyclin B1, for bipolar spindle formation in frog (Rana japonica) oocytes","volume":"59","author":"Kotani","year":"2001","journal-title":"Mol Reprod Dev"},{"key":"10.1016\/j.urolonc.2015.11.011_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.onc.1202263","article-title":"Functional association of TGF-beta receptor II with cyclin B","volume":"18","author":"Liu","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2015.11.011_bib26","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1210\/en.2009-1437","article-title":"The CCAAT\/enhancer binding protein beta is a critical regulator of steroid-induced mitotic expansion of uterine stromal cells during decidualization","volume":"151","author":"Wang","year":"2010","journal-title":"Endocrinology"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143915005633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143915005633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:07:34Z","timestamp":1761041254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143915005633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S1078143915005633"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2015.11.011","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The decrease of cyclin B2 expression inhibits invasion and metastasis of bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2015.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}